Skip to main content

Now live! Explore the program for the upcoming 2024 Global Conference, taking place May 5-8, 2024.

Solving Life-Threatening Problems in Oncology

Solving Life-Threatening Problems in Oncology

Progress in cancer therapy over the last decade has resulted in more patients living longer. But the disease remains the number two cause of death for Americans, and its burden on families and healthcare systems globally continues to be an urgent problem. The discovery and development of new therapies depend on robust, well-funded research and development pipelines in the pharmaceutical and biotechnology industries. Leaders in the field will go over new treatments, as well as the challenges they must overcome to develop the ultimate medicines that will transform cancer from a life-threatening disease to a manageable chronic syndrome.

Howard Soule
Chief Science Officer, Prostate Cancer Foundation

Rajiv Kaul
Portfolio Manager, Select Biotechnology Portfolio and Advisor Biotechnology Fund, Fidelity Investments

Freda Lewis-Hall
Executive Vice President and Chief Medical Officer, Pfizer Inc.

David Reese
Senior Vice President Translational Sciences and Oncology, Amgen Inc.

Mark Simon
Partner and Co-Founder, Torreya Partners